MétaCan
Menu
Back to cohort
Record W2146913502 · doi:10.1158/1078-0432.ccr-08-1572

Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference

2008· review· en· W2146913502 on OpenAlexaff
Robert E. Coleman, Theresa A. Guise, Allan Lipton, G. David Roodman, James R. Berenson, Jean-Jacques Body, Brendan F. Boyce, Laura M. Calvi, Peyman Hadji, Eugène McCloskey, Fred Saad, Matthew R. Smith, Larry J. Suva, Russell S. Taichman, Robert L. Vessella, Katherine N. Weilbaecher

Bibliographic record

VenueClinical Cancer Research · 2008
Typereview
Languageen
FieldMedicine
TopicBone health and treatments
Canadian institutionsCentre Hospitalier de l’Université de MontréalUniversité de MontréalHôpital Notre-Dame
FundersNational Institute of Diabetes and Digestive and Kidney DiseasesNational Cancer Institute
KeywordsMedicineClinical trialMultidisciplinary approachCancerTranslational researchBioinformaticsPathologyBiologyInternal medicine

Abstract

fetched live from OpenAlex

PURPOSE: Summarize current knowledge, critical gaps in knowledge, and recommendations to advance the field of metastatic bone cancer. EXPERIMENTAL DESIGN: A multidisciplinary consensus conference was convened to review recent progress in basic and clinical research, assess critical gaps in current knowledge, and prioritize recommendations to advance research in the next 5 years. The program addressed three principal topics: biology of metastasis, preserving normal bone health, and optimizing bone-targeted therapies. RESULTS: A variety of specific recommendations were identified as important to advance research and clinical care over the next 5 years. CONCLUSIONS: Priorities for research in bone biology include characterizing components of the stem cell niche in bone, developing oncogenic immunocompetent animal models of bone metastasis, and investigating the unique contribution of the bone microenvironment to tumor growth and dormancy. Priorities for research in preserving normal bone health include developing methods to measure and characterize disseminating tumor cells, assessing outcomes from the major prevention trials currently in progress, and improving methodologies to assess risks and benefits of treatment. Priorities for optimizing bone-targeted therapies include advancing studies of serum proteomics and genomics to reliably identify patients who will develop bone metastases, enhancing imaging for early detection of bone metastases and early response evaluation, and developing new tests to evaluate response to bone-directed treatments.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.017
metaresearch head score (Gemma)0.014
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.017
Threshold uncertainty score0.088

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0170.014
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0040.004
Bibliometrics0.0050.004
Science and technology studies0.0010.001
Scholarly communication0.0030.004
Open science0.0050.004
Research integrity0.0090.008
Insufficient payload (model declined to judge)0.0080.005

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.622
GPT teacher head0.637
Teacher spread0.015 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations71
Published2008
Admission routes1
Has abstractyes

Explore more

Same venueClinical Cancer ResearchSame topicBone health and treatmentsFrench-language works237,207